Delivery Order SPE2DX22D0019-SPE2D826FCF88
- Not listed
- On January 7, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order contract valued at $39,640.32 to AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 8, 2026, and represents a task order issued under AmerSourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support...
- This delivery order, awarded January 7, 2026, to AmerSourceBergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency Medical Supply Chain, represents a $15,514.03 firm fixed-price contract with an ultimate completion date of January 8, 2026. The award is not set-aside and was competitively awarded. AmerSourceBergen will perform this contract at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery...
- This delivery order, awarded January 6, 2026, provides $10,009.14 in firm fixed-price pharmaceutical supplies to AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., through the Defense Logistics Agency's Medical Supply Chain. The award represents a single delivery order with an ultimate completion date of January 7, 2026, and carries no set-aside designation, indicating it was competitively awarded. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- This delivery order, awarded on January 7, 2026, represents a $1,663.68 firm fixed-price purchase of pharmaceutical products from AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc. The award was issued by the Defense Logistics Agency's Medical Supply Chain, with a completion date of January 8, 2026. The contract utilizes a non-set-aside competitive procurement process, reflecting the vendor's qualification to compete on a full and open basis for federal medical supply requirements. The...
- This delivery order, awarded to AmerisourceBergen Drug Corp on January 5, 2026, represents a $65,330.55 firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The work will be performed in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,472.63 to AmerSourceBergen Drug Corp on January 7, 2026, for pharmaceutical products and medical supplies to support federal healthcare operations. The award is a non-set-aside, competitively awarded delivery order under a firm fixed-price contract structure, with performance scheduled for completion by January 8, 2026. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- This delivery order, valued at $1,539.85, was awarded on January 6, 2026, to AmerSourceBergen Drug Corp by the Defense Logistics Agency (DLA) without set-aside restrictions. The award represents a task order under AmerSourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of...
- This delivery order, awarded December 15, 2025, represents a $14,651.24 firm fixed-price contract issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made on a competitive, non-set-aside basis, consistent with AmerisourceBergen's...
- On January 7, 2026, the Defense Logistics Agency awarded a delivery order valued at $8,555.21 to AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., for pharmaceutical products and medical supplies. This firm fixed-price delivery order, issued without a set-aside designation, represents a task order executed under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999.999 billion through December 2026. The contract supports federal medical...
- This delivery order, awarded July 21, 2025, represents a $4,038.72 firm fixed-price contract issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency's Medical Supply Chain division. The contract, which is not set-aside and was competitively awarded, is a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The order is scheduled for ultimate completion on July 22, 2025,...
- SPE2DX22D0019Indefinite Delivery Contract
- SPE2DX22D0019-SPE2D826FCF88Delivery Order
This delivery order, awarded on January 7, 2026, represents a firm fixed-price contract valued at $44,830.80 issued to AmerSourceBergen Drug Corp by the Defense Logistics Agency's Medical Supply Chain division. The contract, with an ultimate completion date of January 8, 2026, is a non-set-aside award executed under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor that supplies a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems globally. The parent organization, Cencora, Inc., which does business as AmerSourceBergen, holds the underlying $999,999,999.00 IDC with DLA Troop Support Medical extending through December 2026, serving as the primary vehicle for delivering essential pharmaceutical and medical commodities to military treatment facilities and other federal medical institutions. This delivery order exemplifies the company's capability to efficiently fulfill competitively awarded contracts for specialized pharmaceutical products required by the Department of Defense healthcare infrastructure without set-aside restrictions, demonstrating its established position as a qualified prime vendor within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.8k | 1/6/26 |